期刊
SEMINARS IN IMMUNOPATHOLOGY
卷 37, 期 6, 页码 607-611出版社
SPRINGER HEIDELBERG
DOI: 10.1007/s00281-015-0518-0
关键词
Microglia; Macrophage; NLRP3 inflammasome; beta-amyloid; Alzheimer's disease
资金
- Max Kade Foundation
- NIH [NS059005, AG032349, AI082660]
There is extensive evidence that accumulation of mononuclear phagocytes including microglial cells, monocytes, and macrophages at sites of beta-amyloid (A beta) deposition in the brain is an important pathological feature of Alzheimer's disease (AD) and related animal models, and the concentration of these cells clustered around A beta deposits is several folds higher than in neighboring areas of the brain [1-5]. Microglial cells phagocytose and clear debris, pathogens, and toxins, but they can also be activated to produce inflammatory cytokines, chemokines, and neurotoxins [6]. Over the past decade, the roles of microglial cells in AD have begun to be clarified, and we proposed that these cells play a dichotomous role in the pathogenesis of AD [4, 6-11]. Microglial cells are able to clear soluble and fibrillar A beta, but continued interactions of these cells with A beta can lead to an inflammatory response resulting in neurotoxicity. Inflammasomes are inducible high molecular weight protein complexes that are involved in many inflammatory pathological processes. Recently, A beta was found to activate the NLRP3 inflammasome in microglial cells in vitro and in vivo thereby defining a novel pathway that could lead to progression of AD [12-14]. In this manuscript, we review possible steps leading to A beta-induced inflammasome activation and discuss how this could contribute to the pathogenesis of AD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据